These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 14706335)

  • 1. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.
    Dannenberg AJ; Subbaramaiah K
    Cancer Cell; 2003 Dec; 4(6):431-6. PubMed ID: 14706335
    [No Abstract]   [Full Text] [Related]  

  • 2. COX-2 inhibitors in oncology.
    Haller DG
    Semin Oncol; 2003 Aug; 30(4 Suppl 12):2-8. PubMed ID: 14508721
    [No Abstract]   [Full Text] [Related]  

  • 3. COX-2 in cancer--a player that's defining the rules.
    Hawk ET; Viner JL; Dannenberg A; DuBois RN
    J Natl Cancer Inst; 2002 Apr; 94(8):545-6. PubMed ID: 11959883
    [No Abstract]   [Full Text] [Related]  

  • 4. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
    Housholder GT; Chan JT
    J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
    [No Abstract]   [Full Text] [Related]  

  • 5. The new NSAIDs: cox-2 inhibitors.
    Capriotti T
    Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase enzymes in allergic inflammation and asthma.
    Carey MA; Germolec DR; Langenbach R; Zeldin DC
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):157-62. PubMed ID: 12895598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
    Berenguer B; Alarcón de la Lastra C; Moreno FJ; Martín MJ
    Eur J Pharmacol; 2002 May; 442(1-2):125-35. PubMed ID: 12020690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer.
    Sharma RA
    QJM; 2002 May; 95(5):267-73. PubMed ID: 11978897
    [No Abstract]   [Full Text] [Related]  

  • 9. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 11. Celecoxib: a specific COX-2 inhibitor with anticancer properties.
    Koki AT; Masferrer JL
    Cancer Control; 2002; 9(2 Suppl):28-35. PubMed ID: 11965228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [COX-2].
    Oh-ishi S
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1109-13. PubMed ID: 10771681
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for the observed COX-2/COX-1 selectivity of celecoxib from Monte Carlo simulations.
    Price ML; Jorgensen WL
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1541-4. PubMed ID: 11412976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular perspective: cyclooxygenase-2.
    Goodsell DS
    Oncologist; 2000; 5(2):169-71. PubMed ID: 10794808
    [No Abstract]   [Full Text] [Related]  

  • 16. Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells.
    Johnson AJ; song X; Hsu A; Chen C
    Adv Enzyme Regul; 2001; 41():221-35. PubMed ID: 11384747
    [No Abstract]   [Full Text] [Related]  

  • 17. Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3.
    Lai GH; Zhang Z; Sirica AE
    Mol Cancer Ther; 2003 Mar; 2(3):265-71. PubMed ID: 12657721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of COX-2 inhibitors offer an alternative to NSAIDS in pain management after spinal surgery.
    Reuben SS
    Spine (Phila Pa 1976); 2001 Jul; 26(13):1505-6. PubMed ID: 11458162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].
    Rioda WT; Nervetti A
    Acta Biomed Ateneo Parmense; 2001; 72(3-4):55-64. PubMed ID: 11889908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.